68
Views
0
CrossRef citations to date
0
Altmetric
Review

Quality of life in pediatric brain tumor patients treated with proton therapy: a review of the literature

, &
Pages 329-338 | Received 14 Apr 2016, Accepted 27 May 2016, Published online: 16 Jun 2016

References

  • Young G, Toretsky JA, Campbell AB, et al. Recognition of common childhood malignancies. Am Fam Physician. 2000 [cited 2016 Mar 25];61(7):2144–2154. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10779255
  • Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009;27(14):2308–2318. doi:10.1200/JCO.2009.22.3339
  • Miralbell R, Bleher A, Huguenin P, et al. Pediatric medulloblastoma: radiation treatment technique and patterns of failure. Int J Radiat Oncol. 1997;37(3):523–529. doi:10.1016/S0360-3016(96)00569-X
  • Chang EL, Allen P, Wu C, et al. Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol. 2002;52(4):1008–1016. doi:10.1016/S0360-3016(01)02717-1
  • Back M, Ahern V, Berry M, et al. Importance of radiation time and dose factors on outcome for childhood medulloblastoma. Australas Radiol. 2005;49(4):298–303. doi:10.1111/j.1440-1673.2005.01468.x
  • Armstrong GT, Stovall M, Robison LL. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat Res. 2010;174(6b):840–850. doi:10.1667/RR1903.1
  • Armstrong GT, Liu Q, Yasui Y, et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2009;101(13):946–958. doi:10.1093/jnci/djp148
  • Diller L, Chow EJ, Gurney JG, et al. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol. 2009;27(14):2339–2355. doi:10.1200/JCO.2008.21.1953
  • Mulhern RK, Merchant TE, Gajjar A, et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5(7):399–408. doi:10.1016/S1470-2045(04)01507-4
  • Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil. 2004;7(1):1–14. discussion 15–6. doi:10.1080/13638490310001655528
  • Saha A, Salley CG, Saigal P, et al. Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols. Pediatr Blood Cancer. 2014;61(9):1644–1652. quiz 1653–72. doi:10.1002/pbc.25064
  • Yock TI, Tarbell NJ. Technology insight: proton beam radiotherapy for treatment in pediatric brain tumors. Nat Clin Pract Oncol. 2004;1(2):97–103. quiz 1 p following 111. doi:10.1038/ncponc0090
  • Chang AL, Yock TI, Mahajan A, et al. Pediatric proton therapy: patterns of care across the United States. Int J Part Ther. 2014;1(2):357–367. doi:10.14338/IJPT.13.00009.1
  • Ashley DM, Merchant TE, Strother D, et al. Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children’s Oncology Group study P9934. J Clin Oncol. 2012;30(26):3181–3186. doi:10.1200/JCO.2010.34.4341
  • Merchant TE, Mulhern RK, Krasin MJ, et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol. 2004;22(15):3156–3162. doi:10.1200/JCO.2004.11.142
  • Lannering B, Rutkowski S, Doz F, et al. Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol. 2012;30(26):3187–3193. doi:10.1200/JCO.2011.39.8719
  • The QHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–1409. doi:10.1016/0277-9536(95)00112-K
  • Packer RJ, Zhou T, Holmes E, et al. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children’s Oncology Group trial A9961. Neuro Oncol. 2013;15(1):97–103. doi:10.1093/neuonc/nos267
  • Zeltzer LK, Lu Q, Leisenring W, et al. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 2008;17(2):435–446. doi:10.1158/1055-9965.EPI-07-2541
  • Meeske K, Katz ER, Palmer SN, et al. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia. Cancer. 2004;101(9):2116–2125. doi:10.1002/cncr.20609
  • Macartney G, VanDenKerkhof E, Harrison MB, et al. Symptom experience and quality of life in pediatric brain tumor survivors: a cross-sectional study. J Pain Symptom Manage. 2014;48(5):957–967. doi:10.1016/j.jpainsymman.2013.12.243
  • Meeske KA, Patel SK, Palmer SN, et al. Factors associated with health-related quality of life in pediatric cancer survivors. Pediatr Blood Cancer. 2007;49(3):298–305. doi:10.1002/pbc.20923
  • George AP, Kuehn SM, Vassilyadi M, et al. Cognitive sequelae in children with posterior fossa tumors. Pediatr Neurol. 2003;28(1):42–47. doi:10.1016/S0887-8994(02)00471-X
  • Van Someren E, Swart-Heikens J, Endert E, et al. Long-term effects of cranial irradiation for childhood malignancy on sleep in adulthood. Eur J Endocrinol. 2004;150(4):503–510. doi:10.1530/eje.0.1500503
  • Ris MD, Walsh K, Wallace D, et al. Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma: COG A9961. Pediatr Blood Cancer. 2013;60(8):1350–1357. doi:10.1002/pbc.24496
  • Palmer SN, Meeske KA, Katz ER, et al. The PedsQL Brain Tumor Module: initial reliability and validity. Pediatr Blood Cancer. 2007;49(3):287–293. doi:10.1002/pbc.21026
  • Kahalley LS, Ris MD, Grosshans DR, et al. Comparing intelligence quotient change after treatment with proton versus photon radiation therapy for pediatric brain tumors. J Clin Oncol. 2016. JCO.2015.62.1383. doi:10.1200/JCO.2015.62.1383
  • Pulsifer MB, R V S, Kuhlthau KA, et al. Early cognitive outcomes following proton radiation in pediatric patients with brain and central nervous system tumors. Int J Radiat Oncol Biol Phys. 2015;93(2):400–407. doi:10.1016/j.ijrobp.2015.06.012
  • Huang E, Teh BS, Strother DR, et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol. 2002;52(3):599–605. doi:10.1016/S0360-3016(01)02641-4
  • Orgel E, O’Neil SH, Kayser K, et al. Effect of sensorineural hearing loss on neurocognitive functioning in pediatric brain tumor survivors. Pediatr Blood Cancer. 2016;63(3):527–534. doi:10.1002/pbc.25804
  • Paulino AC, Lobo M, Teh BS, et al. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys. 2010;78(5):1445–1450. doi:10.1016/j.ijrobp.2009.09.031
  • Lin R, Hug EB, Schaefer RA, et al. Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures. Int J Radiat Oncol. 2000;48(4):1219–1226. doi:10.1016/S0360-3016(00)00741-0
  • Abayomi OK. Pathogenesis of irradiation-induced cognitive dysfunction. Acta Oncol. 1996 [cited 2015 Oct 28];35(6):659–663. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8938210.
  • Nieman BJ, de Guzman AE, Gazdzinski LM, et al. White and gray matter abnormalities after cranial radiation in children and mice. Int J Radiat Oncol Biol Phys. 2015;93(4):882–891. doi:10.1016/j.ijrobp.2015.07.2293
  • Schultheiss TE, Kun LE, Ang KK, et al. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys. 1995;31(5):1093–1112. doi:10.1016/0360-3016(94)00655-5
  • Belka C, Budach W, Kortmann RD, et al. Radiation induced CNS toxicity–molecular and cellular mechanisms. Br J Cancer. 2001;85(9):1233–1239. doi:10.1054/bjoc.2001.2100
  • Mostow E, Byrne J, Connelly R, et al. Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol. 1991 [cited 2016 Mar 30];9(4):592–599. Available from: http://jco.ascopubs.org/content/9/4/592.short.
  • Gurney JG, Krull KR, Kadan-Lottick N, et al. Social outcomes in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2390–2395. doi:10.1200/JCO.2008.21.1458
  • Schultz KAP, Ness KK, Whitton J, et al. Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2007;25(24):3649–3656. doi:10.1200/JCO.2006.09.2486
  • Eaton BR, Esiashvili N, Kim S, et al. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol. 2015. doi:10.1093/neuonc/nov302
  • Paulino AC. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys. 2002 [cited 2016 Mar 30];53(3):543–547. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12062595.
  • Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty. J Clin Endocrinol Metab. 1994;78(6):1282–1286. doi:10.1210/jcem.78.6.8200926
  • Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer. 2003;97(3):663–673. doi:10.1002/cncr.11095
  • Xu W, Janss A, Moshang T. Adult height and adult sitting height in childhood medulloblastoma survivors. J Clin Endocrinol Metab. 2003;88(10):4677–4681. doi:10.1210/jc.2003-030619
  • Huang TT, Chen Y, Dietz AC, et al. Pulmonary outcomes in survivors of childhood central nervous system malignancies: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014;61(2):319–325. doi:10.1002/pbc.24819
  • Jakacki RI, Goldwein JW, Larsen RL, et al. Cardiac dysfunction following spinal irradiation during childhood. J Clin Oncol. 1993 [cited 2016 Mar 8];11(6):1033–1038. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8501489.
  • Brown AP, Barney CL, Grosshans DR, et al. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma. Int J Radiat Oncol Biol Phys. 2013;86(2):277–284. doi:10.1016/j.ijrobp.2013.01.014
  • Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2356–2362. doi:10.1200/JCO.2008.21.1920
  • Merchant TE, Li C, Xiong X, et al. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 2009 [cited 2016 Mar 16.];10(3):258–266. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3615425&tool=pmcentrez&rendertype=abstract.
  • Murphy ES, Merchant TE, Wu S, et al. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. Int J Radiat Oncol Biol Phys. 2012;83(5):e655–60. doi:10.1016/j.ijrobp.2012.01.061
  • Landgraf J, Abertz LWJ. Child Health Questionnaire (CHQ): a user’s manual. Boston, MA: The Health Institute, New England Medical Center; 1996.
  • Collier J, MacKinlay D, Phillips D. Norm values for the Generic Children’s Quality of Life Measure (GCQ) from a large school-based sample. Qual Life Res. 2000 [cited 2016 Apr 3];9(6):617–623. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11236852.
  • Varni JW, Limbers CA, Burwinkle TM. Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 Generic Core Scales. Health Qual Life Outcomes. 2007;5:43. doi:10.1186/1477-7525-5-43
  • Varni JW, Burwinkle TM, Seid M, et al. 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. [ cited March 27, 2016];3(6):329–341. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14616041.
  • Varni JW, Burwinkle TM, Katz ER, et al. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002 [cited 2015 Dec 16];94(7):2090–2106. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11932914.
  • Bishop AJ, Greenfield B, Mahajan A, et al. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014;90(2):354–361. doi:10.1016/j.ijrobp.2014.05.051
  • MacDonald SM, Safai S, Trofimov A, et al. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys. 2008;71(4):979–986. doi:10.1016/j.ijrobp.2007.11.065
  • Miralbell R, Lomax A, Russo M. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation. Int J Radiat Oncol. 1997;38(4):805–811. doi:10.1016/S0360-3016(97)00005-9
  • St Clair WH, Adams JA, Bues M, et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys. 2004;58(3):727–734. doi:10.1016/S0360-3016(03)01574-8
  • Tarbell NJ, Smith AR, Adams J, et al. The challenge of conformal radiotherapy in the curative treatment of medulloblastoma. Int J Radiat Oncol. 2000;46(2):265–266. doi:10.1016/S0360-3016(99)00366-1
  • Lee CT, Bilton SD, Famiglietti RM, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys. 2005;63(2):362–372. doi:10.1016/j.ijrobp.2005.01.060
  • Howell RM, Giebeler A, Koontz-Raisig W, et al. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiat Oncol. 2012;7:116. doi:10.1186/1748-717X-7-116
  • Johnstone PAS, McMullen KP, Buchsbaum JC, et al. Pediatric CSI: are protons the only ethical approach? Int J Radiat Oncol Biol Phys. 2013;87(2):228–230. doi:10.1016/j.ijrobp.2013.05.037
  • Wolden SL. Protons for craniospinal radiation: are clinical data important? Int J Radiat Oncol Biol Phys. 2013;87(2):231–232. doi:10.1016/j.ijrobp.2013.05.036
  • Yock TI, Yeap BY, Ebb DH, et al. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016. doi:10.1016/S1470-2045(15)00167-9
  • Moeller BJ, Chintagumpala M, Philip JJ, et al. Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy. Radiat Oncol. 2011;6:58. doi:10.1186/1748-717X-6-58
  • Jimenez RB, Sethi R, Depauw N, et al. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Int J Radiat Oncol Biol Phys. 2013;87(1):120–126. doi:10.1016/j.ijrobp.2013.05.017
  • Song S, Park HJ, Yoon JH, et al. Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors. Acta Oncol. 2014;53(9):1158–1164. doi:10.3109/0284186X.2014.887225
  • Macdonald SM, Sethi R, Lavally B, et al. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro Oncol. 2013;15(11):1552–1559. doi:10.1093/neuonc/not121
  • Amsbaugh MJ, Grosshans DR, McAleer MF, et al. Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes. Int J Radiat Oncol Biol Phys. 2012;83(5):1419–1424. doi:10.1016/j.ijrobp.2011.10.034
  • Luu QT, Loredo LN, Archambeau JO, et al. Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J. [ cited 2016 Jan 18];12(2):155–159. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16630407.
  • Laffond C, Dellatolas G, Alapetite C, et al. Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj. 2012;26(3):270–281. doi:10.3109/02699052.2011.648709
  • Monje M, Beachy PA, Fisher PG. Hedgehogs, flies, Wnts and MYCs: the time has come for many things in medulloblastoma. J Clin Oncol. 2011;29(11):1395–1398. doi:10.1200/JCO.2010.34.0547
  • Murray MJ, Bartels U, Nishikawa R, et al. Consensus on the management of intracranial germ-cell tumours. Lancet Oncol. 2015;16(9):e470–7. doi:10.1016/S1470-2045(15)00244-2
  • Lundkvist J, Ekman M, Ericsson SR, et al. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer. 2005;103(4):793–801. doi:10.1002/cncr.20844
  • Verma V, Mishra MV, Mehta MP. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy. Cancer. 2016. doi:10.1002/cncr.29882
  • Indelicato DJ, Flampouri S, Rotondo RL, et al. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol. 2014;53(10):1298–1304. doi:10.3109/0284186X.2014.957414
  • Kuhlthau KA, Pulsifer MB, Yeap BY, et al. Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol. 2012;30(17):2079–2086. doi:10.1200/JCO.2011.37.0577
  • Yock TI, Bhat S, Szymonifka J, et al. Quality of life outcomes in proton and photon treated pediatric brain tumor survivors. Radiother Oncol. 2014;113(1):89–94. doi:10.1016/j.radonc.2014.08.017
  • Kiehna EN, Merchant TE. Radiation therapy for pediatric craniopharyngioma. Neurosurg Focus. 2010;28(4):E10. doi:10.3171/2010.1.FOCUS09297

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.